Trial Information

Summary: Aripiprozole in At-Risk Children with symptoms of Bipolar Disorder

Condition: Pediatric Bipolar Disorder

Study Description: Research has shown that children of parents with bipolar disorder are at higher risk for developing a bipolar disorder than other children. This study will examine the efficacy of aripiprazole (AbilifyÒ) in the stabilization of mood in this group of young people. Eligible patients who satisfy screening criteria will be closely monitored with frequent clinical visits with a physician. Clinical care, evaluations, mediations and laboratory tests done as part of the study will be provided at no cost to the participant.

Patient Inclusion Criteria: Participants should include boys and girls between the ages of 5 and 17, who are experiencing mood shifts, sadness and elation and have at least one parent diagnosed with bipolar disorder and has another relative with a mood disorder.

Patient Exclusion Criteria: Participants should include boys and girls between the ages of 5 and 17, who are experiencing mood shifts, sadness and elation and have at least one parent diagnosed with bipolar disorder and has another relative with a mood disorder.

Intervention Type: Drug

Intervention Name: Aripiprazole

Study Type: Interventional

Study Start Date: 05-2003

Target Number Of Subjects: 60

If you would like to learn more about participating in this study, please send an e-mail message using the form below.